Enterprise Therapeutics

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.

EpiEndo Pharmaceuticals

This biopharmaceutical company develops oral, non-antibiotic therapies to treat chronic respiratory diseases, such as COPD, for patients requiring anti-inflammatory and barrier-strengthening treatments.

Expedition Therapeutics

This biotechnology company develops oral small molecule therapies for patients with serious inflammatory and respiratory diseases, including chronic obstructive pulmonary disease.

Alentar

This company develops therapeutic agents to reverse goblet cell hyperplasia for patients with cystic fibrosis and other pulmonary conditions.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.